SOLV · Solventum Corp · Executive Compensation
$86.09
+1.04 (+1.22%)
At close · Oct 20
Return incl. dividend (before tax)
Market Cap
$14.48B
Shares
170.22M
Volume · Oct 20
130.81K
Avg daily vol (3M)
1.04M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Bryan Hanson | Chief Executive Officer | $20,139,981 |
| Heather Knight | Chief Commercial Officer | $7,917,906 |
| Wayde McMillan | Chief Financial Officer | $6,165,583 |
| Christopher Barry | Former EVP and Group President, Medical Surgical | $4,232,003 |
| Marcela A. Kirberger | Chief Corporate & Legal Officer | $3,594,017 |
| Amy L. Landucci | Chief Information & Digital Officer | $3,464,975 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Bryan Hanson | Chief Executive Officer | $39,959,767 |
| Wayde McMillan | Chief Financial Officer | $10,321,753 |
| Christopher Barry | EVP and Group President, Medical Surgical | $9,763,527 |
| Amy L. Landucci | Chief Information & Digital Officer | $9,070,517 |
| Tammy L. Gomez | Chief Human Resource Officer | $4,957,367 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Neil Zieselman | Senior Vice President, Controller and Chief Accounting Officer | Appointed | 2026-07-20 |
| Heather Knight | Chief Commercial Officer | Appointed | 2025-10-21 |
| Shirley A. Edwards | Class II director | Appointed | 2024-04-16 |
| Theresa E. Reinseth | Director | Resigned | 2024-04-04 |
| Michael J. Ottesen | Director | Resigned | 2024-04-04 |
| Teresa K. Crockett | Director | Resigned | 2024-04-04 |
| Rodolfo Espinosa-Casaubon | Director | Resigned | 2024-04-04 |
| Carrie S. Cox | Chairman of the Board | Appointed | 2024-04-04 |
| Amy A. Wendell | Director | Appointed | 2024-04-04 |
| Darryl L. Wilson | Director | Appointed | 2024-04-04 |
| John H. Weiland | Director | Appointed | 2024-04-04 |
| Elizabeth A. Mily | Director | Appointed | 2024-04-04 |
| Karen J. May | Director | Appointed | 2024-04-04 |
| Bernard A. Harris Jr. | Director | Appointed | 2024-04-04 |
| Glenn A. Eisenberg | Director | Appointed | 2024-04-04 |
| Bryan Hanson | Director | Appointed | 2024-04-04 |
| Susan D. DeVore | Director | Appointed | 2024-04-04 |
| Carrie S. Cox | Director | Appointed | 2024-04-04 |
| Carlos Albán | Director | Appointed | 2024-04-04 |
| Tammy Gomez | Chief Human Resources Officer | Appointed | 2024-04-04 |
| Amy Landucci | Chief Information and Digital Officer | Appointed | 2024-04-04 |
| Paul Harrington | Chief Supply Chain Officer | Appointed | 2024-04-04 |
| Chris Barry | Executive Vice President and Group President, Medical Solutions | Appointed | 2024-04-04 |
| Mary Wilcox | Senior Vice President, Controller and Chief Accounting Officer | Appointed | 2024-04-04 |
| Marcela Kirberger | Chief Legal Affairs Officer, Corporate Secretary | Appointed | 2024-04-04 |
Leadership
- Carrie S. Cox Chairman, Board Member
- Amy Landucci CIO
- Marcela Kirberger General Counsel
- Mary Wilcox Chief Accounting Officer
- Neil Zieselman Chief Accounting Officer
- Amy A. Wendell Board Member
- Bernard A. Harris Jr. Board Member
- Bryan Hanson Board Member
- Carlos Albán Board Member
- Darryl L. Wilson Board Member
- Elizabeth A. Mily Board Member
- Glenn A. Eisenberg Board Member
- John H. Weiland Board Member
- Karen J. May Board Member
- Shirley A. Edwards Board Member
- Susan D. DeVore Board Member
Key facts
CIK
1964738
CUSIP
83444M101
13F (30d)
138 filings
118 filers
Visit website
Investor relations